Search Results - "Fedenko, A. A."

Cyclosporine combined with eltrombopag for treatment of secondary graft failure after autologous hematopoietic stem cell transplantation by Semochkin, S. V., Lunin, V. V., Kaplanskaya, I. B., Fedenko, A. A.

“…Graft failure (GF) is an extremely rare complication of autologous hematopoietic stem cell transplantation (auto-HSCT) with a frequency not exceeding 3–5 % of…”
Get full text

OPTIMAL SEQUENCE OF APPLICATION OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVATING EGFR MUTATIONS by Kolomeytseva, A. A., Fedenko, A. A.

“…Background. Successful treatment of patients with EG FR-positive non-small cell lung cancer (NSCLC ) is directly related to epidermal growth factor receptor…”
Get full text

Key issues of patient safety during anticancer drug treatment in a day hospital and outpatient setting by Fedenko, A. A., Kolomeytseva, A. A., Artemova, V. O.

“…Background. In the context of the ongoing COVID-19 pandemic, the vector of healthcare development is aimed at minimizing contacts among citizens, which is…”
Get full text

Total neoadjuvant chemotherapy according to the FOLFIRINOX regimen for locally advanced adenocarcinoma of the stomach and cardioesophageal junction: interim results by M. V. Sedova, M. A. Batov, A. A. Kolomeytseva, V. M. Khomyakov, N. N. Volchenko, A. A. Fedenko

“…Purpose. To study the efficacy and safety of total neoadjuvant chemotherapy (NACT) with the FOLFIRINOX regimen for locally advanced gastric (GC) and…”
Get full text

A rare case of solitary fibrous pelvic tumor by L. O. Petrov, D. A. Golovkov, R. I. Moshurov, S. S. Malev, A. A. Fedenko

“…Non-organ retroperitoneal tumors are a heterogeneous group of malignant neoplasms that develop from different types of connective tissue, which in turn…”
Get full text

Liposarcomas: morphological subtypes, prognostic factors and therapeutic options by Fedenko, A.A.

“…The article shows the literature review of the biology, prognostic factors and the results of liposarcomas treatment according to the histological subtypes and…”
Get full text

The Debut of Inflammatory Musculoskeletal Pathology in Patients Receiving Anticancer Therapy with PD-1/PD-L1 Pathway Inhibitors by Koltakova, A. D., Lila, A. M., Alekseeva, O. G., Fedenko, A. A., Gridneva, Y. V., Olshanskaya, A. S.

“…Objective : to describe musculoskeletal immune-mediated adverse events (iAEs) associated with the therapy of solid tumors with immune checkpoint inhibitors…”
Get full text

Immunochemotherapy of refractory classical Hodgkin's lymphoma with high-dose consolidation and autologous hematopoietic stem cell transplantation complicated by a new coronavirus infection by Khayrullina, L. S., Vernyuk, M. A., Chervontseva, A. M., Cherkashina, I. V., Gushchina, E. E., Fedenko, A. A.

“…Classical Hodgkin's lymphoma is one of the most treatable lymphoproliferative diseases with current chemotherapy regimens. The 5-year overall survival rate…”
Get full text

Bone marrow composition features and possibilities of tumor involvement diagnosing in patients with classic Hodgkin’s lymphoma by Abbasbeyli, F. M., Zeynalova, P. A., Vernyuk, M. A., Fedenko, A. A., Mushkarina, T. Yu, Melnikova, A. A., Kovalskaya, V. Yu, Grivtsova, L. Yu

“…   Background. Classical Hodgkin’s lymphoma is a B-cell lymphoproliferative disease, the tumor substrate of which is Berezovsky–Reed–Sternberg cells,…”
Get full text

Clinical possibilities of flow cytometry in hodgkin’s lymphoma by Abbasbeyli, F. M., Fedenko, A. A., Zeynalova, P. A., Zibirov, R. F., Grinevich, V. N., Mushkarina, T. Yu, Melnikova, A. A., Vernyuk, M. A., Grivtsova, L. Yu

“…   Hodgkin’s lymphoma (HL) is a unique lymphoma of b-cell origin, the tumor cells of which have lost the expression of main b-cell antigens. The standard…”
Get full text

Dynamics of urinary kim-1 as a biomarker of acute kidney injury in cancer patients undergoing cisplatin-based chemotherapy by Sergeeva, N. S., Karmakova, T. A., Savchina, V. V., Deshkina, T. I., Karpenko, E. Yu, Bolotina, L. V., Alentov, I. I., Marshutina, N. V., Fedenko, A. A.

“…Platinum is the main component of the most chemotherapy (CT) regimens, but their use may be limited because of nephrotoxicity. Kidney injury molecule 1 (KIM-1)…”
Get full text

Early progression of follicular lymphoma: a view of the problem and personal experience by Vernyuk, M. A., Chervontseva, A. M., Cherkashina, I. V., Gushchina, E. E., Khayrullina, L. S., Fedenko, A. A.

“…Follicular lymphoma (FL) refers to indolent mature B-cell lymphomas and, despite the recurrent course, is generally characterized by a favorable prognosis with…”
Get full text

Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer by M. V. Sedova, M. A. Batov, V. S. Tretyak, A. A. Kolomeytseva, V. M. Khomyakov, N. N. Volchenko, A. A. Fedenko, A. D. Kaprin

“…Gastric cancer (GC) is the fifth most common malignant neoplasm in the world among all malignant tumors. Currently, the “gold” standard of treatment for…”
Get full text

Efficacy of enzalutamide in patients with metastatic hormone-sensitive and castration-refractory prostate cancer: authors’ experience by Ustinova, T. V., Bolotina, L. V., Paichadze, A. A., Kachmazov, A. A., Fedenko, A. A., Kaprin, A. D.

“…Prostate cancer is one of the most common neoplasms in men. It currently ranks second in Russian Federation amongst male population in overall number of cases…”
Get full text

Results of complex treatment of patients with locally advanced squamous cell carcinoma of the paranasal sinuses and nasal cavity using induction chemotherapy by Dеshkina, T.   I., Bolotina, L.  V., Gevorkov, A.  R., Boyko, A.  V., Kornietskaya, A.  L., Polyakov, A. P., Golubev, P.   V., Sydykova, R.  S., Fedenko, A. A.

“…Introduction. About 600 new cases of malignant neoplasms of the paranasal sinuses and nasal cavity are detected annually in Russia. To date, there are no…”
Get full text

Induction chemotherapy with docetaxel and doxorubicin followed by proton beam radiation therapy for platinum-resistant unresectable sinonasal undifferentiated carcinoma by Kachmazov, A. A., Bolotina, L. V., Kornietskaya, A. L., Tolstov, V. A., Fedenko, A. A.

“…Sinonasal undifferentiated carcinoma is a rare and aggressive tumor with an extremely poor prognosis. In the vast majority of cases, this tumor can not be…”
Get full text

DRUG THERAPY FOR ANDROGEN-POSITIVE BREAST CANCER by Zikiryakhodjhaev, A. D., Fedenko, A. A., Starkova, M. V., Surkova, V. S., Sedova, M. V.

“…There are some types of breast cancer (BC) that depend on their molecular characteristics. However, lately researchers provide date regarding the presence of…”
Get full text

EXPERIENCE IN THE TREATMENT OF REFRACTORY HODGKIN’S LYMPHOMA by Chervontseva, A. M., Verniuk, M. A., Gushchina, E. E., Cherkashina, I. V., Fedenko, A. A.

“…Background. The use of modern induction chemotherapy programs for primary Hodgkin’s lymphoma allows achievement of high long-term outcomes even in patients…”
Get full text

Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma by Bolotina, L. V., Ustinova, T. V., Dеshkina, T. I., Golubev, P. V., Lyubavina, N. N., Fedenko, A. A., Kaprin, A. D.

“…This article discusses current approaches to first-line chemotherapy for non-resectable head and neck squamous cell carcinoma and describes factors affecting…”
Get full text

Neuroendocrine cancer of maxillary sinus: case report and literature review by Deshkina, T. I., Bolotina, L. V., Gevorkov, A. R., Boyko, A. V., Surkova, V. S., Sedova, M. V., Polyakov, A. P., Kornietskaya, A. L., Fedenko, A. A.

“…Malignant tumors of the sinuses and nasal cavity are rare diseases. Squamous cell carcinoma is the most common histological type (55–70 % of tumors of the…”
Get full text